Publication | Open Access

6-bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists

Molecular PharmacologyBiochemistryMedicinePharmacological AgentPharmacotherapy6-Bicyclopiperidinyl-1-arylsulfonylindoles DerivativesPharmacologyDerivative (Chemistry)Drug Discovery